Incidence and risk factors of severe adverse events with nevirapine-based antiretroviral therapy in HIV-infected women. MTCT-Plus program, Abidjan, Côte d'Ivoire

<p>Abstract</p> <p>Background</p> <p>In resource-limited settings where nevirapine-containing regimen is the preferred regimen in women, data on severe adverse events (SAEs) according to CD4 cell count are limited. We estimated the incidence of SAEs according to CD4 cell count and identify their ris...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Amani-Bosse Clarisse, Tanon Aristophane K, Tonwe-Gold Besigin, Coffie Patrick A, Bédikou Gédéon, Abrams Elaine J, Dabis François, Ekouevi Didier K
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	BMC 2010-06-01
Schriftenreihe:	BMC Infectious Diseases
Online-Zugang:	http://www.biomedcentral.com/1471-2334/10/188
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!